Copyright Reports & Markets. All rights reserved.

Global Ketorolac Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Concentration
    • 1.3.1 Overview: Global Ketorolac Injection Consumption Value by Concentration: 2019 Versus 2023 Versus 2030
    • 1.3.2 15mg/ml
    • 1.3.3 30mg/ml
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Ketorolac Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Clinics
    • 1.4.4 Others
  • 1.5 Global Ketorolac Injection Market Size & Forecast
    • 1.5.1 Global Ketorolac Injection Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Ketorolac Injection Sales Quantity (2019-2030)
    • 1.5.3 Global Ketorolac Injection Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Ketorolac Injection Product and Services
    • 2.1.4 Pfizer Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Fresenius Kabi
    • 2.2.1 Fresenius Kabi Details
    • 2.2.2 Fresenius Kabi Major Business
    • 2.2.3 Fresenius Kabi Ketorolac Injection Product and Services
    • 2.2.4 Fresenius Kabi Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Fresenius Kabi Recent Developments/Updates
  • 2.3 Fosun Pharma (Gland Pharma)
    • 2.3.1 Fosun Pharma (Gland Pharma) Details
    • 2.3.2 Fosun Pharma (Gland Pharma) Major Business
    • 2.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Product and Services
    • 2.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Fosun Pharma (Gland Pharma) Recent Developments/Updates
  • 2.4 Sagent Pharmaceuticals
    • 2.4.1 Sagent Pharmaceuticals Details
    • 2.4.2 Sagent Pharmaceuticals Major Business
    • 2.4.3 Sagent Pharmaceuticals Ketorolac Injection Product and Services
    • 2.4.4 Sagent Pharmaceuticals Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Sagent Pharmaceuticals Recent Developments/Updates
  • 2.5 Hikma
    • 2.5.1 Hikma Details
    • 2.5.2 Hikma Major Business
    • 2.5.3 Hikma Ketorolac Injection Product and Services
    • 2.5.4 Hikma Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Hikma Recent Developments/Updates
  • 2.6 Lunan Pharma
    • 2.6.1 Lunan Pharma Details
    • 2.6.2 Lunan Pharma Major Business
    • 2.6.3 Lunan Pharma Ketorolac Injection Product and Services
    • 2.6.4 Lunan Pharma Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Lunan Pharma Recent Developments/Updates
  • 2.7 Alvogen
    • 2.7.1 Alvogen Details
    • 2.7.2 Alvogen Major Business
    • 2.7.3 Alvogen Ketorolac Injection Product and Services
    • 2.7.4 Alvogen Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Alvogen Recent Developments/Updates
  • 2.8 Chengdu Brilliant Pharmaceuticals
    • 2.8.1 Chengdu Brilliant Pharmaceuticals Details
    • 2.8.2 Chengdu Brilliant Pharmaceuticals Major Business
    • 2.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product and Services
    • 2.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
  • 2.9 Athenex
    • 2.9.1 Athenex Details
    • 2.9.2 Athenex Major Business
    • 2.9.3 Athenex Ketorolac Injection Product and Services
    • 2.9.4 Athenex Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Athenex Recent Developments/Updates
  • 2.10 Sichuan Medcalo
    • 2.10.1 Sichuan Medcalo Details
    • 2.10.2 Sichuan Medcalo Major Business
    • 2.10.3 Sichuan Medcalo Ketorolac Injection Product and Services
    • 2.10.4 Sichuan Medcalo Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Sichuan Medcalo Recent Developments/Updates
  • 2.11 Julphar Bangladesh Ltd.
    • 2.11.1 Julphar Bangladesh Ltd. Details
    • 2.11.2 Julphar Bangladesh Ltd. Major Business
    • 2.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Product and Services
    • 2.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Julphar Bangladesh Ltd. Recent Developments/Updates
  • 2.12 Yung Shin Pharm
    • 2.12.1 Yung Shin Pharm Details
    • 2.12.2 Yung Shin Pharm Major Business
    • 2.12.3 Yung Shin Pharm Ketorolac Injection Product and Services
    • 2.12.4 Yung Shin Pharm Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Yung Shin Pharm Recent Developments/Updates
  • 2.13 Tianjin Chase Sun Pharmaceutical
    • 2.13.1 Tianjin Chase Sun Pharmaceutical Details
    • 2.13.2 Tianjin Chase Sun Pharmaceutical Major Business
    • 2.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product and Services
    • 2.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments/Updates
  • 2.14 ZISKA Pharmaceuticals
    • 2.14.1 ZISKA Pharmaceuticals Details
    • 2.14.2 ZISKA Pharmaceuticals Major Business
    • 2.14.3 ZISKA Pharmaceuticals Ketorolac Injection Product and Services
    • 2.14.4 ZISKA Pharmaceuticals Ketorolac Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 ZISKA Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Ketorolac Injection by Manufacturer

  • 3.1 Global Ketorolac Injection Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Ketorolac Injection Revenue by Manufacturer (2019-2024)
  • 3.3 Global Ketorolac Injection Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Ketorolac Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Ketorolac Injection Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Ketorolac Injection Manufacturer Market Share in 2023
  • 3.5 Ketorolac Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Ketorolac Injection Market: Region Footprint
    • 3.5.2 Ketorolac Injection Market: Company Product Type Footprint
    • 3.5.3 Ketorolac Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ketorolac Injection Market Size by Region
    • 4.1.1 Global Ketorolac Injection Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Ketorolac Injection Consumption Value by Region (2019-2030)
    • 4.1.3 Global Ketorolac Injection Average Price by Region (2019-2030)
  • 4.2 North America Ketorolac Injection Consumption Value (2019-2030)
  • 4.3 Europe Ketorolac Injection Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Ketorolac Injection Consumption Value (2019-2030)
  • 4.5 South America Ketorolac Injection Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Ketorolac Injection Consumption Value (2019-2030)

5 Market Segment by Concentration

  • 5.1 Global Ketorolac Injection Sales Quantity by Concentration (2019-2030)
  • 5.2 Global Ketorolac Injection Consumption Value by Concentration (2019-2030)
  • 5.3 Global Ketorolac Injection Average Price by Concentration (2019-2030)

6 Market Segment by Application

  • 6.1 Global Ketorolac Injection Sales Quantity by Application (2019-2030)
  • 6.2 Global Ketorolac Injection Consumption Value by Application (2019-2030)
  • 6.3 Global Ketorolac Injection Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Ketorolac Injection Sales Quantity by Concentration (2019-2030)
  • 7.2 North America Ketorolac Injection Sales Quantity by Application (2019-2030)
  • 7.3 North America Ketorolac Injection Market Size by Country
    • 7.3.1 North America Ketorolac Injection Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Ketorolac Injection Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Ketorolac Injection Sales Quantity by Concentration (2019-2030)
  • 8.2 Europe Ketorolac Injection Sales Quantity by Application (2019-2030)
  • 8.3 Europe Ketorolac Injection Market Size by Country
    • 8.3.1 Europe Ketorolac Injection Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Ketorolac Injection Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ketorolac Injection Sales Quantity by Concentration (2019-2030)
  • 9.2 Asia-Pacific Ketorolac Injection Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Ketorolac Injection Market Size by Region
    • 9.3.1 Asia-Pacific Ketorolac Injection Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Ketorolac Injection Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Ketorolac Injection Sales Quantity by Concentration (2019-2030)
  • 10.2 South America Ketorolac Injection Sales Quantity by Application (2019-2030)
  • 10.3 South America Ketorolac Injection Market Size by Country
    • 10.3.1 South America Ketorolac Injection Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Ketorolac Injection Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ketorolac Injection Sales Quantity by Concentration (2019-2030)
  • 11.2 Middle East & Africa Ketorolac Injection Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Ketorolac Injection Market Size by Country
    • 11.3.1 Middle East & Africa Ketorolac Injection Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Ketorolac Injection Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Ketorolac Injection Market Drivers
  • 12.2 Ketorolac Injection Market Restraints
  • 12.3 Ketorolac Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ketorolac Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ketorolac Injection
  • 13.3 Ketorolac Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ketorolac Injection Typical Distributors
  • 14.3 Ketorolac Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Ketorolac injection is used for the short-term treatment of moderate to severe pain. It is usually used before or after medical procedures or after surgery. Reducing pain helps you recover more comfortably so that you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug.
    According to our (Global Info Research) latest study, the global Ketorolac Injection market size was valued at US$ 988 million in 2023 and is forecast to a readjusted size of USD 1182 million by 2030 with a CAGR of 2.6% during review period.
    Global key ketorolac injection 核心厂商 Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma) etc. The top 2 companies hold a share about 20%. North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.
    This report is a detailed and comprehensive analysis for global Ketorolac Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Concentration and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Ketorolac Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/K Units), 2019-2030
    Global Ketorolac Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/K Units), 2019-2030
    Global Ketorolac Injection market size and forecasts, by Concentration and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/K Units), 2019-2030
    Global Ketorolac Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/K Units), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Ketorolac Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Ketorolac Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals, Athenex, Sichuan Medcalo, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Ketorolac Injection market is split by Concentration and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Concentration, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Concentration
    15mg/ml
    30mg/ml
    Market segment by Application
    Hospital
    Clinics
    Others
    Major players covered
    Pfizer
    Fresenius Kabi
    Fosun Pharma (Gland Pharma)
    Sagent Pharmaceuticals
    Hikma
    Lunan Pharma
    Alvogen
    Chengdu Brilliant Pharmaceuticals
    Athenex
    Sichuan Medcalo
    Julphar Bangladesh Ltd.
    Yung Shin Pharm
    Tianjin Chase Sun Pharmaceutical
    ZISKA Pharmaceuticals
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Ketorolac Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Ketorolac Injection, with price, sales quantity, revenue, and global market share of Ketorolac Injection from 2019 to 2024.
    Chapter 3, the Ketorolac Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Ketorolac Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Concentration and by Application, with sales market share and growth rate by Concentration, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Ketorolac Injection market forecast, by regions, by Concentration, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Ketorolac Injection.
    Chapter 14 and 15, to describe Ketorolac Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now